Enhancing Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized Trial
Developing and Testing an Intervention to Enhance Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized Trial of Linkage to Recovery Support Services
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Lauren A Hoffman, PhD
- Phone Number: (617) 643-4690
- Email: lhoffman1@mgh.harvard.edu
Study Contact Backup
- Name: John F Kelly, PhD
- Phone Number: (617) 643-1980
- Email: jkelly11@mgh.harvard.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
Contact:
- Lauren A Hoffman, PhD
- Phone Number: 617-643-4690
- Email: lhoffman1@mgh.harvard.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age ≥ 18 years
- past-year opioid use disorder diagnosis per the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
- currently undergoing outpatient buprenorphine treatment through a provider or program at Massachusetts General Hospital
- current residence in Massachusetts
Exclusion Criteria:
- non-English fluency
- active suicidality
- neurodevelopmental disorders or neural trauma preventing informed consent
- active psychosis
- past-year attendance at a recovery community center or recovery support center
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Recovery Community Center Linkage (RCCL)
The RCCL arm will involve a brief (~20 minutes) meeting with a recovery coach (i.e.
linkage manager), in which the recovery coach will inform the participant of recovery support services, including recovery community centers, and link them to a recovery community center, with the aid of a facilitated connection to a volunteer recovery community center member (i.e.
peer facilitator).
The linkage manager will also provide the participant with a list of recovery support service resources.
|
A certified recovery coach will meet with participants to educate them on recovery support services, including recovery community centers, and link them to a recovery community center, with the aid of a facilitated connection to a volunteer recovery community center member (e.g., calling a standby peer, scheduling a meet-up at the center).
The coach will also provide the participant with a brochure of recovery support resources.
|
|
Active Comparator: Control Condition (CC)
The CC arm will involve a time-matched meeting with a recovery coach (i.e.
linkage manager), in which the recovery coach will broadly inform the participant of recovery support services, including recovery community centers, and provide them with a list of recovery support service resources.
|
A certified recovery coach will meet with participants to educate them on recovery support services more broadly, including recovery community centers, and will provide them with a brochure of recovery support resources.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall recruitment feasibility
Time Frame: Through study completion, ~3 years from recruitment initiation
|
Number of participants successfully recruited within allotted recruitment time frame (~3 years)
|
Through study completion, ~3 years from recruitment initiation
|
|
Overall intervention satisfaction
Time Frame: Month 1
|
Assessed via the Client Satisfaction Questionnaire-8 (CSQ8) total score.
This is an 8 item measure of client satisfaction with services.
Total scores range from 8 to 32, with higher scores indicating greater satisfaction.
|
Month 1
|
|
Recovery community center attendance
Time Frame: From the date of linkage manager meeting until the date of month-3 follow up, assessed up to 3 months
|
Percent of participants who attended a recovery community center 1+ time post linkage manager meeting, as assessed via the Timeline Follow Back
|
From the date of linkage manager meeting until the date of month-3 follow up, assessed up to 3 months
|
|
Use of recovery support services
Time Frame: From the date of linkage manager meeting until the date of month-3 follow up, assessed up to 3 months
|
Percent days use of any recovery support services post linkage manager meeting, as assessed via the Timeline Follow Back
|
From the date of linkage manager meeting until the date of month-3 follow up, assessed up to 3 months
|
|
Overall intervention feasibility
Time Frame: From the date of intervention manual finalization until the date of study completion, assessed up to 48 months
|
Assessed via the Feasibility: Intervention Implementation & Training scale average total score.
This is a 2-item instrument to assess perceived intervention feasibility.
Items are measured on a 6-point Likert scale (Strongly Disagree-Strongly Agree).
Score is the calculated mean.
Higher scores indicate greater feasibility.
|
From the date of intervention manual finalization until the date of study completion, assessed up to 48 months
|
|
Fidelity: Linkage manager adherence
Time Frame: From date of first linkage manager meeting until the date of last linkage manager meeting, assessed up to 36 months
|
Percent adherence of linkage managers to intervention protocols, as evaluated by the percentage of sessions that are scored with adequate adherence and assessed by recordings of intervention delivery and adherence evaluation materials developed as part of Aim 1 (e.g., adherence rating scales of critical topics).
This is a 14-item instrument evaluating the extensiveness of linkage managers' delivery of critical intervention topics.
Items are measured on a 5-point Likert scale (Not at all - Extensively).
Score is the calculated mean.
Total scores range from 1 to 5, with scores > 3 indicating adequate adherence.
|
From date of first linkage manager meeting until the date of last linkage manager meeting, assessed up to 36 months
|
|
Overall intervention acceptability
Time Frame: Month 1
|
Assessed via 1 single-item statement addressing the the acceptability of the intervention.
The item is measured on a 6-point Likert scale (Strongly Disagree - Strongly Agree).
Higher scores indicate greater acceptability.
|
Month 1
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant retention
Time Frame: From the date of first participant enrollment in the trial to the date of study completion, up to 42 months
|
Percent of enrolled participants who complete Month 3 Follow-Up
|
From the date of first participant enrollment in the trial to the date of study completion, up to 42 months
|
|
Feasibility of peer facilitator meet-ups
Time Frame: Month 1; Month 3
|
Percent of peer facilitator meet-ups occurring within 2 weeks of participant's linkage manager meeting
|
Month 1; Month 3
|
|
Intervention appropriateness
Time Frame: Month 1
|
Assessed via the Intervention Appropriateness Measure (IAM; adapted for study parameters) average total score.
This is a 4-item instrument to assess perceived intervention appropriateness.
Items are measured on a 5-point Likert scale (Strongly Disagree-Strongly Agree).
Score is the calculated mean.
Higher scores indicate greater appropriateness.
|
Month 1
|
|
Intervention helpfulness
Time Frame: Month 1; Month 3
|
Assessed via 4 single-item statements addressing the intervention's helpfulness in general and helpfulness to supporting treatment and opioid use disorder recovery.
Items are measured on a 6-point Likert scale (Strongly Disagree-Strongly Agree).
Score is the response for each item.
Higher scores indicate greater helpfulness.
|
Month 1; Month 3
|
|
Change in recovery capital from baseline to Month 3
Time Frame: Baseline; Month 1; Month 3
|
Assessed via the REC-CAP Inventory total score.
Scores range from -100 to +100, with higher scores indicating greater recovery capital.
|
Baseline; Month 1; Month 3
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2021P003720
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.